Compare XNET & INNV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | XNET | INNV |
|---|---|---|
| Founded | 2003 | 2007 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Medical/Nursing Services |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 446.3M | 485.4M |
| IPO Year | 2014 | 2021 |
| Metric | XNET | INNV |
|---|---|---|
| Price | $7.50 | $5.32 |
| Analyst Decision | | Sell |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $5.00 |
| AVG Volume (30 Days) | ★ 388.9K | 153.7K |
| Earning Date | 11-13-2025 | 02-03-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 8740.73 | N/A |
| EPS | ★ 20.16 | N/A |
| Revenue | $401,918,000.00 | ★ $884,662,000.00 |
| Revenue This Year | N/A | $11.18 |
| Revenue Next Year | N/A | $9.58 |
| P/E Ratio | $0.38 | ★ N/A |
| Revenue Growth | ★ 27.19 | 12.48 |
| 52 Week Low | $1.90 | $2.60 |
| 52 Week High | $11.03 | $6.26 |
| Indicator | XNET | INNV |
|---|---|---|
| Relative Strength Index (RSI) | 55.50 | 48.61 |
| Support Level | $7.07 | $5.17 |
| Resistance Level | $7.44 | $5.85 |
| Average True Range (ATR) | 0.34 | 0.31 |
| MACD | 0.09 | -0.05 |
| Stochastic Oscillator | 64.06 | 19.12 |
Xunlei Ltd is a cloud-based acceleration technology company in China. The company operates a powerful internet platform in China based on cloud computing to provide users with quick and easy access to digital media content through its products and services, Xunlei Accelerator, and cloud acceleration subscription services. It is increasingly extending into mobile devices in part through potentially pre-installed acceleration products in mobile phones Xunlei has developed various value-added services to meet a fuller spectrum of its users' digital media content access and consumption needs.
InnovAge Holding Corp is a healthcare delivery platform by several participants focused on providing all-inclusive, capitated care to high-cost, dual-eligible seniors. Its patient-centered care delivery approach improves the quality of care while keeping them in their homes and reducing over-utilization of high-cost care settings such as hospitals and nursing homes. The company's segment includes PACE and others. It generates maximum revenue from the PACE segment.